163.65
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$164.00
Offen:
$164.3
24-Stunden-Volumen:
4.72M
Relative Volume:
0.89
Marktkapitalisierung:
$261.24B
Einnahmen:
$113.07B
Nettoeinkommen (Verlust:
$16.33B
KGV:
16.80
EPS:
9.7438
Netto-Cashflow:
$20.03B
1W Leistung:
-1.43%
1M Leistung:
+3.85%
6M Leistung:
+36.13%
1J Leistung:
+40.05%
Morgan Stanley Stock (MS) Company Profile
Firmenname
Morgan Stanley
Sektor
Branche
Telefon
212-761-4000
Adresse
1585 BROADWAY, NEW YORK, NY
Vergleichen Sie MS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MS
Morgan Stanley
|
163.65 | 260.92B | 113.07B | 16.33B | 20.03B | 9.7438 |
|
GS
Goldman Sachs Group Inc
|
785.52 | 236.75B | 122.70B | 16.67B | 66.86B | 49.23 |
|
SCHW
Charles Schwab Corp
|
93.15 | 171.57B | 27.16B | 8.23B | 39.40B | 4.266 |
|
HOOD
Robinhood Markets Inc
|
147.08 | 130.44B | 3.59B | 1.79B | 876.00M | 1.9688 |
|
IBKR
Interactive Brokers Group Inc
|
73.08 | 31.33B | 9.76B | 3.77B | 33.07B | 4.6205 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-07-09 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-09-11 | Herabstufung | Goldman | Buy → Neutral |
| 2024-08-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-01-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-17 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-11-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-11-20 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | Herabstufung | Odeon | Buy → Hold |
| 2023-10-20 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-07 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-12 | Hochstufung | Odeon | Hold → Buy |
| 2023-01-18 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-10 | Hochstufung | Odeon | Sell → Hold |
| 2023-01-04 | Herabstufung | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | Herabstufung | Odeon | Hold → Sell |
| 2022-05-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-28 | Herabstufung | Odeon | Buy → Hold |
| 2021-12-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | Bestätigt | Jefferies | Buy |
| 2021-09-29 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-09-28 | Herabstufung | Berenberg | Buy → Hold |
| 2021-08-13 | Herabstufung | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | Fortgesetzt | Keefe Bruyette | Outperform |
| 2021-06-09 | Eingeleitet | Jefferies | Buy |
| 2021-04-21 | Hochstufung | Berenberg | Hold → Buy |
| 2021-03-02 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-11-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-10-13 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-06-24 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-06-23 | Bestätigt | UBS | Buy |
| 2020-05-21 | Hochstufung | Odeon | Hold → Buy |
| 2020-04-14 | Hochstufung | Societe Generale | Sell → Buy |
| 2020-03-13 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-21 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-02-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-01-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | Eingeleitet | DA Davidson | Buy |
| 2020-01-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-29 | Herabstufung | Odeon | Buy → Hold |
| 2019-10-10 | Hochstufung | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-04-18 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Morgan Stanley Aktie (MS) Neueste Nachrichten
Morgan Stanley Buys EquityZen in Private Markets Push - Bloomberg.com
GenAI Boom Rewrites Investment Handbook: Morgan Stanley - Finance News Network
More Confidence in a Bull Market - Morgan Stanley
E*TRADE from Morgan Stanley Releases Monthly Sector Rotation Study - Bluefield Daily Telegraph
Form 424B2 MORGAN STANLEY - StreetInsider
Morgan Stanley Maintains Goldman Sachs(GS.US) With Hold Rating, Maintains Target Price $828 - 富途牛牛
Key facts: Chevron gains U.S. approval for Venezuela operations; Q3 profits up 20%; Morgan Stanley raises price target - TradingView
BioNTech price target raised to $134 from $131 at Morgan Stanley - TipRanks
Morgan Stanley Lowers Price Target for FMC to $17.00 | FMC Stock News - GuruFocus
Merck & Co (MRK) Analyst Rating Update by Morgan Stanley | MRK S - GuruFocus
MELI: Morgan Stanley Raises Price Target for MercadoLibre | MELI Stock News - GuruFocus
SPHR: Morgan Stanley Raises Price Target Despite Maintaining Equ - GuruFocus
Charles Schwab (SCHW) Receives Upgraded Price Target from Morgan Stanley | SCHW Stock News - GuruFocus
Colgate-Palmolive (CL) Price Target Lowered by Morgan Stanley | - GuruFocus
JC Britt: Morgan Stanley Advisor Lands Options Complaint - carlsonlaw.com
Merck & Co., Inc. (NYSE:MRK) Given New $100.00 Price Target at Morgan Stanley - MarketBeat
FMC Earnings Expected to Miss Estimates Amid Falling Volume, Pricing Pressure, Morgan Stanley Says - MarketScreener
Morgan Stanley Adjusts Price Target on Microchip Technology to $68 From $63 - MarketScreener
Sandisk's Stock Sees Risk-Reward Profile 'More Balanced' in Short Term, Morgan Stanley Says - MarketScreener
Earnings Growth Will Be Better Than Expected, Morgan Stanley's Wilson Says - MarketScreener
Colgate-Palmolive Likely to See Organic Sales Growth Improvement, Morgan Stanley Says - MarketScreener
Morgan Stanley Raises Opendoor (OPEN) Price Target, Keeps Hold Rating - Yahoo Finance
Siemens Energy hits record high as Morgan Stanley boosts outlook - TradingView
Morgan Stanley issues shock take on the stock market - TheStreet
REGEuronext DublinGEMMSBVEARLY REDEMPTION -03rd Nov 2025 (MORGAN STANLEY B.V.) [83492] - TradingView
Morgan Stanley cuts Spain's Solaria to 'underweight' on valuation - TradingView
Morgan Stanley’s Wilson Sees Need for 150 Bps of Fed Rate Cuts - Bloomberg.com
Morgan Stanley Maintains Charles Schwab(SCHW.US) With Buy Rating, Raises Target Price to $139 - 富途牛牛
Merck price target raised to $100 from $98 at Morgan Stanley - TipRanks
Earnings are supporting stocks, but there are two risks to watch, says Morgan Stanley - MSN
Morgan Stanley Lowers Price Target on Newell Brands to $4.25 From $5.25, Keeps Equalweight Rating - MarketScreener
Morgan Stanley Lowers Price Target on Werner Enterprises to $36 From $40, Keeps Overweight Rating - MarketScreener
Morgan Stanley flags two near-term risks facing U.S. stock markets - Investing.com
Hunter Associates Investment Management LLC Sells 6,504 Shares of Morgan Stanley $MS - MarketBeat
Morgan Stanley discloses minor trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley lifts H1 2026 Brent forecast to $60 on OPEC+ pause, Russia sanctions - Reuters
SanDisk stock price target raised to $230 from $96 at Morgan Stanley - Investing.com
Smurfit Westrock price target lowered to $52 from $56 at Morgan Stanley - Investing.com
Versor Investments LP Increases Stake in Morgan Stanley $MS - MarketBeat
Morgan Stanley downgrades Solaria stock to Underweight despite raising price target - Investing.com
Bank Of America Feels The Heat To Catch Up With Rivals - Finimize
Phoenix Education initiated with an Overweight at Morgan Stanley - TipRanks
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals - Investing.com
1,791 Shares in Morgan Stanley $MS Acquired by Atlas Private Wealth Advisors - MarketBeat
TIAA Trust National Association Raises Stock Holdings in Morgan Stanley $MS - MarketBeat
AI’s rapid progress still short of transformative breakthrough, says Morgan Stanley (XLK:NYSEARCA) - Seeking Alpha
Morgan Stanley lifts A2A to top pick, stock climbs 6% on €3.25 call - Investing.com
Frasers Property and MSREI expand alliance with A$500m logistics deal - IPE Real Assets
Morgan Stanley lifts first-half 2026 Brent forecast to $60 due to Russia sanctions - TradingView
Morgan Stanley initiates Phoenix Education Partners stock with Overweight rating - Investing.com
Morgan Stanley: 2026 Will Be the Year of AI Technology Hardware - 富途牛牛
Finanzdaten der Morgan Stanley-Aktie (MS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):